The goals of the Genetic analysis core are: 1) To obtain and process buccal cell specimens from 40,000 participants in the NHS to supplement the DNA obtained from collection; 2) To provide fast, efficient, and accurate genotyping to Project investigators at the lowest possible cost. The core will manage the dispatch of kits for cheek cell collection by mail, and will process and archive these on return; this will be accomplished in Year 1. In years 1-5 we will: 1) Conduct DNA extraction DNA extraction and genotyping for germline polymorphism in CYP1A2, and NAT1, NAT, MnSOD, and MTHFR (Project 1), CYP1A2, NAT1, NAT2, and MTHFR (Project 2), and GALT and AR (Project 3). Germline DNA will be extracted from stored buffy goats, cheek cell samples, and normal tissue from tumor blocks; 2) Assess methylation status of CpG islands in the promoter regions of ER and p16 (Project 1) and p16 (Project 2). The existence of the Core will permit genotyping to proceed, efficiently, and additional efficiencies will be achieved as several of the genotypes overlap between the projects permitting some economies of scale. The minimal geographic separation of the core facility from the investigators will also facilitate rapid communication of priorities for analyses, speedy interpretation of results of and resolution of any questions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA087969-03
Application #
6595023
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Kosumi, Keisuke; Hamada, Tsuyoshi; Koh, Hideo et al. (2018) The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol 188:2839-2852
Nevo, Daniel; Nishihara, Reiko; Ogino, Shuji et al. (2018) The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure. Lifetime Data Anal 24:425-442
Xu, Yinghui; Wang, Yanru; Liu, Hongliang et al. (2018) Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog 57:22-31
Ma, Siyuan; Ogino, Shuji; Parsana, Princy et al. (2018) Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol 19:142
Drucker, Aaron M; Li, Wen-Qing; Cho, Eunyoung et al. (2018) Shingles and pneumonia and risk of cutaneous basal and squamous cell carcinoma. J Am Acad Dermatol :
Li, Wen-Qing; Cho, Eunyoung; Wu, Shaowei et al. (2018) Host characteristics and risk of incident melanoma by Breslow thickness. Cancer Epidemiol Biomarkers Prev :
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Butt, Julia; Blot, William J; Teras, Lauren R et al. (2018) Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 27:1186-1194
Ma, Wenjie; Heianza, Yoriko; Huang, Tao et al. (2018) Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women. Int J Epidemiol 47:311-320
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647

Showing the most recent 10 out of 1708 publications